The OARS-7 study is researching an investigational medication added to an existing antidepressant for adults who still struggle with symptoms of depression.
see if you qualifyDepression can be difficult to manage, even when taking an antidepressant. Many people continue to feel symptoms such as low mood, fatigue, or loss of interest in daily activities. The OARS-7 clinical research study aims to learn more about an investigational medication that is added to a person’s current antidepressant to see how it may help.
Participants continue their usual SSRI or SNRI medication while receiving either the investigational medication or a placebo during the study. Through health evaluations, check-ins, and study visits, the research team gathers important information about safety, effectiveness, and duration of effect.
By taking part, you may help contribute to research that could support future understanding and treatment of depression.
.png){kind=icon}
Conducted in Atlanta, GA 30318, United States
Individuals diagnosed with depression
.png){kind=icon}
Must be on one SSRI or SNRI for at least 6 weeks
Some improvement but less than 50% relief
.png)
This study is evaluating an investigational medication added to a current antidepressant to understand its safety, how well it works, and how long its effects last.
No. Participants continue their current SSRI or SNRI throughout the study.
Participants attend in-person visits at a local research site in Atlanta, GA 30318, United States to complete screening and study procedures.
No, you will not need to paid to participate.
You will receive study-related medical care and investigational medication or placebo at no cost.
The study will not cover other medical care or medications you need for your regular health care.
